Evidence map›Paper›PMID 37284565›Full record

ArticleArchivos peruanos de cardiologia y cirugia cardiovascular

[Cardiac progression of systemic light chain amyloidosis].

Diego Xavier Chango Azanza, Ruth Lizbeth Fernández Tirado, Valeria Verenisse López Pillaga, José David Tello Ochoa, Javier Fernando Pinos Vásquez

Open access · diamondAbstract readCase ReportsEnglish Abstract
In one paragraph

Article in Archivos peruanos de cardiologia y cirugia cardiovascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Diego Xavier Chango AzanzaHospital del Rio, Cuenca, Ecuador. Hospital del Rio Cuenca Ecuador.ORCID https://orcid.org/0000-0002-6376-3051
Ruth Lizbeth Fernández TiradoUniversidad Catolica de Cuenca, Cuenca, Ecuador. Universidad Católica de Cuenca Universidad Catolica de Cuenca Cuenca Ecuador.ORCID https://orcid.org/0000-0001-7237-6136
Valeria Verenisse López PillagaUniversidad Catolica de Cuenca, Cuenca, Ecuador. Universidad Católica de Cuenca Universidad Catolica de Cuenca Cuenca Ecuador.ORCID https://orcid.org/0000-0001-6524-8558
José David Tello OchoaUniversidad Catolica de Cuenca, Cuenca, Ecuador. Universidad Católica de Cuenca Universidad Catolica de Cuenca Cuenca Ecuador.ORCID https://orcid.org/0000-0002-0179-5189
Javier Fernando Pinos VásquezHospital del Rio, Cuenca, Ecuador. Hospital del Rio Cuenca Ecuador.ORCID https://orcid.org/0000-0003-3922-9702
Universidad Católica de Cuenca · ECUniversity of Cuenca · EC

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic light chain amyloidosis is a disease characterized by the accumulation of amyloid protein in multiple organs and systems. We present the case of a 52-year-old male patient with a diagnosis of systemic light chain amyloidosis associated with cardiac and renal involvement. A renal biopsy showed the presence of renal amyloidosis associated with proteinuria, and the patient was referred for cardiovascular evaluation. The baseline electrocardiogram showed micro voltage in frontal leads that were discordant with the left ventricular hypertrophy evidenced in the transthoracic echocardiogram (TTE). Cardiac magnetic resonance imaging (CMR) confirmed the presence of cardiac amyloid infiltration with a pattern of extensive ventricular late-gadolinium enhancement. Despite being referred and receiving specific systemic chemotherapy treatment, the evolution was not favorable after four months of follow-up with worsening cardiac infiltration, increasing values of biomarkers, and progression of dyspnea. The TTE was useful in revealing the unfavorable evolution and worsening of diastolic function parameters and increased wall thickness in the context of infiltration. The electrocardiogram and echocardiogram were easily accessible tools that allowed the monitoring of the response to treatment.

Indexed as

CardiomyopathiesEchocardiographyElectrocardiographyHeart FailureInmunoglobulin Light-chain Amyloidosis

Identifiers

PMID37284565
PMCPMC10241332
OpenAlexW4320503101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.